206 related articles for article (PubMed ID: 37566748)
1. SLC1A5 is a novel biomarker associated with ferroptosis and the tumor microenvironment: a pancancer analysis.
Chen P; Jiang Y; Liang J; Cai J; Zhuo Y; Fan H; Yuan R; Cheng S; Zhang Y
Aging (Albany NY); 2023 Aug; 15(15):7451-7475. PubMed ID: 37566748
[TBL] [Abstract][Full Text] [Related]
2. SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma.
Han L; Zhou J; Li L; Wu X; Shi Y; Cui W; Zhang S; Hu Q; Wang J; Bai H; Liu H; Guo C; Cao H; Chao M; Hu Y; Mou Y; Jiao Y; Feng D; Wang L; Qu Y
Cell Death Dis; 2022 Dec; 13(12):1071. PubMed ID: 36566214
[TBL] [Abstract][Full Text] [Related]
3. Identify an innovative ferroptosis-related gene in hepatocellular carcinoma.
Hu G; Huang X; Zhang B; Gao P; Wu W; Wang J
J Clin Lab Anal; 2022 Sep; 36(9):e24632. PubMed ID: 35908779
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer.
Wang F; Chen C; Chen WP; Li ZL; Cheng H
Biomed Res Int; 2021; 2021():6014202. PubMed ID: 34708125
[TBL] [Abstract][Full Text] [Related]
5. Ferroptosis in Low-Grade Glioma: A New Marker for Diagnosis and Prognosis.
Liu Y; Xu Z; Jin T; Xu K; Liu M; Xu H
Med Sci Monit; 2020 Jun; 26():e921947. PubMed ID: 32484805
[TBL] [Abstract][Full Text] [Related]
6. Glutamine Transporter SLC1A5 Regulates Ionizing Radiation-Derived Oxidative Damage and Ferroptosis.
Yuan Z; Liu T; Huo X; Wang H; Wang J; Xue L
Oxid Med Cell Longev; 2022; 2022():3403009. PubMed ID: 36262284
[TBL] [Abstract][Full Text] [Related]
7. A Carbonic Anhydrase IX/SLC1A5 Axis Regulates Glutamine Metabolism Dependent Ferroptosis in Hypoxic Tumor Cells.
Venkateswaran G; McDonald PC; Chafe SC; Brown WS; Gerbec ZJ; Awrey SJ; Parker SJ; Dedhar S
Mol Cancer Ther; 2023 Oct; 22(10):1228-1242. PubMed ID: 37348875
[TBL] [Abstract][Full Text] [Related]
8. Circ_0001273 downregulation inhibits the growth, migration and glutamine metabolism of esophageal cancer cells via targeting the miR-622/SLC1A5 signaling axis.
Wu B; Chen Y; Chen Y; Xie X; Liang H; Peng F; Che W
Thorac Cancer; 2022 Jun; 13(12):1795-1805. PubMed ID: 35567340
[TBL] [Abstract][Full Text] [Related]
9. Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer.
Hassanein M; Qian J; Hoeksema MD; Wang J; Jacobovitz M; Ji X; Harris FT; Harris BK; Boyd KL; Chen H; Eisenberg R; Massion PP
Int J Cancer; 2015 Oct; 137(7):1587-97. PubMed ID: 25821004
[TBL] [Abstract][Full Text] [Related]
10. SLC1A5 Silencing Inhibits Esophageal Cancer Growth via Cell Cycle Arrest and Apoptosis.
Lin J; Yang T; Peng Z; Xiao H; Jiang N; Zhang L; Ca D; Wu P; Pan Q
Cell Physiol Biochem; 2018; 48(1):397. PubMed ID: 30071532
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive molecular and clinical characterization of SLC1A5 in human cancers.
Zhang H; Cui K; Yao S; Yin Y; Liu D; Huang Z
Pathol Res Pract; 2021 Aug; 224():153525. PubMed ID: 34171602
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis of Ferroptosis Regulators with Regard to PD-L1 and Immune Infiltration in Low-Grade Glioma.
Luan Y; Chen Y; Wang Y; Shu M
Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629061
[TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-related local immune cytolytic activity in tumor microenvironment of basal cell and squamous cell carcinoma.
Wang J; Xie D; Wu H; Li Y; Wan C
Aging (Albany NY); 2022 May; 14(9):3956-3972. PubMed ID: 35501667
[TBL] [Abstract][Full Text] [Related]
14. Glutamine addiction activates polyglutamine-based nanocarriers delivering therapeutic siRNAs to orthotopic lung tumor mediated by glutamine transporter SLC1A5.
Wang C; Wu J; Wang Z; Yang Z; Li Z; Deng H; Li L; Peng X; Feng M
Biomaterials; 2018 Nov; 183():77-92. PubMed ID: 30149232
[TBL] [Abstract][Full Text] [Related]
15. Ferroptosis-related gene SLC1A5 is a novel prognostic biomarker and correlates with immune infiltrates in stomach adenocarcinoma.
Zhu D; Wu S; Li Y; Zhang Y; Chen J; Ma J; Cao L; Lyu Z; Hou T
Cancer Cell Int; 2022 Mar; 22(1):124. PubMed ID: 35305616
[TBL] [Abstract][Full Text] [Related]
16. SLC1A5 mediates glutamine transport required for lung cancer cell growth and survival.
Hassanein M; Hoeksema MD; Shiota M; Qian J; Harris BK; Chen H; Clark JE; Alborn WE; Eisenberg R; Massion PP
Clin Cancer Res; 2013 Feb; 19(3):560-70. PubMed ID: 23213057
[TBL] [Abstract][Full Text] [Related]
17. Correlation Between Prognostic Biomarker
Zhao J; Yang Z; Tu M; Meng W; Gao H; Li MD; Li L
Front Oncol; 2021; 11():608641. PubMed ID: 34367941
[TBL] [Abstract][Full Text] [Related]
18. Targeting of the glutamine transporter SLC1A5 induces cellular senescence in clear cell renal cell carcinoma.
Kawakami I; Yoshino H; Fukumoto W; Tamai M; Okamura S; Osako Y; Sakaguchi T; Inoguchi S; Matsushita R; Yamada Y; Tatarano S; Nakagawa M; Enokida H
Biochem Biophys Res Commun; 2022 Jun; 611():99-106. PubMed ID: 35487063
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of 33 human cancers reveals clinical implications and immunotherapeutic value of the solute carrier family 35 member A2.
Xu S; Chen X; Fang J; Chu H; Fang S; Zeng L; Ma H; Zhang T; Chen Y; Wang T; Zhang X; Shen T; Zheng Y; Xu D; Lu Z; Pan Y; Liu Y
Front Immunol; 2023; 14():1155182. PubMed ID: 37275857
[TBL] [Abstract][Full Text] [Related]
20. Circ_0000463 contributes to the progression and glutamine metabolism of non-small-cell lung cancer by targeting miR-924/SLC1A5 signaling.
Liu Y; Wang S; Pan S; Yan Q; Li Y; Zhao Y
J Clin Lab Anal; 2022 Jan; 36(1):e24116. PubMed ID: 34811815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
